Explore more publications!

Press Releases

U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
Church Leaders Can Harness Might for Right: empty tomb’s The State of Church Giving through 2022 (2025 edition)
Jason Kelce Invests in New Jersey Cult-Favorite Hank Sauce, Bringing Flavor to More U.S. Households
Attorney General Bonta Joins Multistate Letter Opposing EPA’s Proposal to Weaken PFAS Reporting

Attorney General Bonta Joins Multistate Letter Opposing EPA’s Proposal to Weaken PFAS Reporting

New Grant Program Funds Food Security Initiatives

New Grant Program Funds Food Security Initiatives

Church’s Texas Chicken® Steps in the Ring with World Champion Boxer Amanda Serrano
Children’s Book MY COOKING INQUISITION Serves Up Rhymes and Recipes for Early Readers
Analyzing the Factors Behind the Best Steam Boiler Price: ZOZEN’s Guide to Efficiency and Reliability
Top 10 Steam Boiler Manufacturers In The World: ZOZEN's Edge with ASME and CE Certification
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
World's Largest Beverage Chain MIXUE Opens in Hollywood with Support from Elevate Crest Properties
Documentary ‘Third Degree Burnout – A Survivor’s Guide’ Receives United Nations International Impact Award
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
U.S. Restaurant Industry Faces ‘Hyper-Competition,’ Average 3-5% Profit Margin Pushing 78% of Owners to Burnout.
Trends in Plant-Based Food Bioplastics Market 2025-35
HYTN Welcomes U.S. Executive Order Initiating Cannabis Reclassification to Schedule III
Alba Wheels Up International, LLC Launches Direct Mexico–U.S. East Coast Ocean Service for Meat and Perishables
Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth
In the Immediate Aftermath of Cyber Monday, Nearly Half of U.S. Adults (48%) Bought Something an AI Tool Recommended
Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions